Cargando…

Azithromycin effectiveness against intracellular infections of Francisella

BACKGROUND: Macrolide antibiotics are commonly administered for bacterial respiratory illnesses. Azithromycin (Az) is especially noted for extremely high intracellular concentrations achieved within macrophages which is far greater than the serum concentration. Clinical strains of Type B Francisella...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Saira, Hunter, Lyman, Qin, Aiping, Mann, Barbara J, van Hoek, Monique L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881020/
https://www.ncbi.nlm.nih.gov/pubmed/20416090
http://dx.doi.org/10.1186/1471-2180-10-123
_version_ 1782182075413037056
author Ahmad, Saira
Hunter, Lyman
Qin, Aiping
Mann, Barbara J
van Hoek, Monique L
author_facet Ahmad, Saira
Hunter, Lyman
Qin, Aiping
Mann, Barbara J
van Hoek, Monique L
author_sort Ahmad, Saira
collection PubMed
description BACKGROUND: Macrolide antibiotics are commonly administered for bacterial respiratory illnesses. Azithromycin (Az) is especially noted for extremely high intracellular concentrations achieved within macrophages which is far greater than the serum concentration. Clinical strains of Type B Francisella (F.) tularensis have been reported to be resistant to Az, however our laboratory Francisella strains were found to be sensitive. We hypothesized that different strains/species of Francisella (including Type A) may have different susceptibilities to Az, a widely used and well-tolerated antibiotic. RESULTS: In vitro susceptibility testing of Az confirmed that F. tularensis subsp. holarctica Live Vaccine Strain (LVS) (Type B) was not sensitive while F. philomiragia, F. novicida, and Type A F. tularensis (NIH B38 and Schu S4 strain) were susceptible. In J774A.1 mouse macrophage cells infected with F. philomiragia, F. novicida, and F. tularensis LVS, 5 μg/ml Az applied extracellularly eliminated intracellular Francisella infections. A concentration of 25 μg/ml Az was required for Francisella-infected A549 human lung epithelial cells, suggesting that macrophages are more effective at concentrating Az than epithelial cells. Mutants of RND efflux components (tolC and ftlC) in F. novicida demonstrated less sensitivity to Az by MIC than the parental strain, but the tolC disc-inhibition assay demonstrated increased sensitivity, indicating a complex role for the outer-membrane transporter. Mutants of acrA and acrB mutants were less sensitive to Az than the parental strain, suggesting that AcrAB is not critical for the efflux of Az in F. novicida. In contrast, F. tularensis Schu S4 mutants ΔacrB and ΔacrA were more sensitive than the parental strain, indicating that the AcrAB may be important for Az efflux in F. tularensis Schu S4. F. novicida LPS O-antigen mutants (wbtN, wbtE, wbtQ and wbtA) were found to be less sensitive in vitro to Az compared to the wild-type. Az treatment prolonged the survival of Galleria (G.) mellonella infected with Francisella. CONCLUSION: These studies demonstrate that Type A Francisella strains, as well as F. novicida and F. philomiragia, are sensitive to Az in vitro. Francisella LPS and the RND efflux pump may play a role in Az sensitivity. Az also has antimicrobial activity against intracellular Francisella, suggesting that the intracellular concentration of Az is high enough to be effective against multiple strains/species of Francisella, especially in macrophages. Az treatment prolonged survival an in vivo model of Francisella-infection.
format Text
id pubmed-2881020
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28810202010-06-05 Azithromycin effectiveness against intracellular infections of Francisella Ahmad, Saira Hunter, Lyman Qin, Aiping Mann, Barbara J van Hoek, Monique L BMC Microbiol Research article BACKGROUND: Macrolide antibiotics are commonly administered for bacterial respiratory illnesses. Azithromycin (Az) is especially noted for extremely high intracellular concentrations achieved within macrophages which is far greater than the serum concentration. Clinical strains of Type B Francisella (F.) tularensis have been reported to be resistant to Az, however our laboratory Francisella strains were found to be sensitive. We hypothesized that different strains/species of Francisella (including Type A) may have different susceptibilities to Az, a widely used and well-tolerated antibiotic. RESULTS: In vitro susceptibility testing of Az confirmed that F. tularensis subsp. holarctica Live Vaccine Strain (LVS) (Type B) was not sensitive while F. philomiragia, F. novicida, and Type A F. tularensis (NIH B38 and Schu S4 strain) were susceptible. In J774A.1 mouse macrophage cells infected with F. philomiragia, F. novicida, and F. tularensis LVS, 5 μg/ml Az applied extracellularly eliminated intracellular Francisella infections. A concentration of 25 μg/ml Az was required for Francisella-infected A549 human lung epithelial cells, suggesting that macrophages are more effective at concentrating Az than epithelial cells. Mutants of RND efflux components (tolC and ftlC) in F. novicida demonstrated less sensitivity to Az by MIC than the parental strain, but the tolC disc-inhibition assay demonstrated increased sensitivity, indicating a complex role for the outer-membrane transporter. Mutants of acrA and acrB mutants were less sensitive to Az than the parental strain, suggesting that AcrAB is not critical for the efflux of Az in F. novicida. In contrast, F. tularensis Schu S4 mutants ΔacrB and ΔacrA were more sensitive than the parental strain, indicating that the AcrAB may be important for Az efflux in F. tularensis Schu S4. F. novicida LPS O-antigen mutants (wbtN, wbtE, wbtQ and wbtA) were found to be less sensitive in vitro to Az compared to the wild-type. Az treatment prolonged the survival of Galleria (G.) mellonella infected with Francisella. CONCLUSION: These studies demonstrate that Type A Francisella strains, as well as F. novicida and F. philomiragia, are sensitive to Az in vitro. Francisella LPS and the RND efflux pump may play a role in Az sensitivity. Az also has antimicrobial activity against intracellular Francisella, suggesting that the intracellular concentration of Az is high enough to be effective against multiple strains/species of Francisella, especially in macrophages. Az treatment prolonged survival an in vivo model of Francisella-infection. BioMed Central 2010-04-23 /pmc/articles/PMC2881020/ /pubmed/20416090 http://dx.doi.org/10.1186/1471-2180-10-123 Text en Copyright ©2010 Ahmad et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Ahmad, Saira
Hunter, Lyman
Qin, Aiping
Mann, Barbara J
van Hoek, Monique L
Azithromycin effectiveness against intracellular infections of Francisella
title Azithromycin effectiveness against intracellular infections of Francisella
title_full Azithromycin effectiveness against intracellular infections of Francisella
title_fullStr Azithromycin effectiveness against intracellular infections of Francisella
title_full_unstemmed Azithromycin effectiveness against intracellular infections of Francisella
title_short Azithromycin effectiveness against intracellular infections of Francisella
title_sort azithromycin effectiveness against intracellular infections of francisella
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881020/
https://www.ncbi.nlm.nih.gov/pubmed/20416090
http://dx.doi.org/10.1186/1471-2180-10-123
work_keys_str_mv AT ahmadsaira azithromycineffectivenessagainstintracellularinfectionsoffrancisella
AT hunterlyman azithromycineffectivenessagainstintracellularinfectionsoffrancisella
AT qinaiping azithromycineffectivenessagainstintracellularinfectionsoffrancisella
AT mannbarbaraj azithromycineffectivenessagainstintracellularinfectionsoffrancisella
AT vanhoekmoniquel azithromycineffectivenessagainstintracellularinfectionsoffrancisella